BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28829502)

  • 1. Expression of long non-coding RNA linc-ITGB1 in breast cancer and its influence on prognosis and survival.
    Li WX; Sha RL; Bao JQ; Luan W; Su RL; Sun SR
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3397-3401. PubMed ID: 28829502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
    Qu CH; Sun QY; Zhang FM; Jia YM
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased long noncoding RNA LINP1 expression and its prognostic significance in human breast cancer.
    Liu XM; Yang B; Han J
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8749-8754. PubMed ID: 30575915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer.
    Zhang XF; Liu T; Li Y; Li S
    Int J Clin Exp Pathol; 2015; 8(8):9440-5. PubMed ID: 26464701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of long non-coding RNA MEG3 serves as an unfavorable risk factor for survival of patients with breast cancer.
    Zhang JJ; Guo SH; Jia BQ
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5143-5147. PubMed ID: 28051255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism].
    Pan GF; Zhou XF; Zhao JP
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):102-108. PubMed ID: 28219204
    [No Abstract]   [Full Text] [Related]  

  • 7. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
    Zhao T; Wu L; Li X; Dai H; Zhang Z
    Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA Loc554202 expression as a prognostic factor in patients with colorectal cancer.
    Yang L; Wei H; Xiao HJ
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4243-4247. PubMed ID: 27831651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of long non-coding RNA PCAT-1 correlates with tumor progression and poor prognosis in gastric cancer.
    Cui WC; Wu YF; Qu HM
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3021-3027. PubMed ID: 28742205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
    Deng X; Zhao Y; Wu X; Song G
    Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer.
    Yang Y; Qian J; Xiang Y; Chen Y; Qu J
    Oncotarget; 2017 Jan; 8(4):6833-6844. PubMed ID: 28036281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of long non-coding RNA GAS5 is associated with poor prognosis of patients with thyroid cancer.
    Guo LJ; Zhang S; Gao B; Jiang Y; Zhang XH; Tian WG; Hao S; Zhao JJ; Zhang G; Hu CY; Yan J; Luo DL
    Exp Mol Pathol; 2017 Jun; 102(3):500-504. PubMed ID: 28506768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA MVIH is associated with poor prognosis and malignant biological behavior in breast cancer.
    Lei B; Xu SP; Liang XS; Li YW; Zhang JF; Zhang GQ; Pang D
    Tumour Biol; 2016 Apr; 37(4):5257-64. PubMed ID: 26555546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
    Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of long non-coding RNA Linc-A associates with poor survival in patients with colorectal cancer.
    Zhao C; Gan C; Xiao Y; Liu R; Zhang L; Lan T; Ye Y; Tong H; Huang Z; Tang C; Gao J
    Mol Biol Rep; 2020 Oct; 47(10):7497-7504. PubMed ID: 32918124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer.
    Zhang HH; Li AH
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3357-3362. PubMed ID: 29917186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer.
    Xu SP; Zhang JF; Sui SY; Bai NX; Gao S; Zhang GW; Shi QY; You ZL; Zhan C; Pang D
    Tumour Biol; 2015 Dec; 36(12):9807-12. PubMed ID: 26159853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA linc-UBC1 is negative prognostic factor and exhibits tumor pro-oncogenic activity in gastric cancer.
    Hu Y; Pan J; Wang Y; Li L; Huang Y
    Int J Clin Exp Pathol; 2015; 8(1):594-600. PubMed ID: 25755750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
    Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.